Company History

  • June 2012

    China Biologic received manufacturing approval certificate for Human Coagulation Factor VIII from China Food and Drug Administration (“CFDA”).
  • October 2011

    Forbes magazine again named China Biologic to its annual list of Asia’s “200 Best Under a Billion.”
  • July 2011

    Shandong Taibang’s newly built plasma collection station in Ningyang county obtained plasma collection license from the Shandong Provincial Health Department and commenced commercial plasma collection.
  • January 2011

    China Biologic purchased the remaining 10% equity in Guiyang Dalin Biologic Technologies Co., Ltd.
FirstPage | PreviousPage | NextPage | LastPage CurrentPageIndex:4 [1] [2] [3] [4] [5] [6] [7] 
© 2014 China Biologic Products, Inc. All Rights Reserved.